April 11, 2019
Teva Announces Launch of a Generic Version of AndroGel® (testosterone gel) 1.62% CIII in the United States
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) todayannounced the launch of a generic version of AndroGel ®i(testosterone gel) 1.62% CIII in the U.S.